Alzheimer's Disease (Incl Subtypes)
16
3
4
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
2 terminated out of 16 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Improving PCP Advance Care Planning for People With ADRD
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
Sirtuin-NAD Activator in Alzheimer's Disease
Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension
Hypnosis for Sleep Quality in Caregivers of Individuals With Alzheimer's Disease
Beyond Listening: A Music-based Intervention
Improvisational Movement for People With Memory Loss and Their Caregivers
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension
Vietnamese Caregiver Intervention Study
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping
Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech
Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping